EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer’s Disease

Koral V Wheeler, Andrei Irimia, Meredith N Braskie

Journal of Alzheimer’s Disease · 2024

DOI: 10.3233/jad-230553 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Koral V Wheeler und 2 weiteren Autor:innen. Beteiligte Einrichtung: Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Ma…. Hauptthemen laut MEDLINE: Alzheimer Disease, Cerebral Amyloid Angiopathy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 277 Literaturangaben. Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral amyloid angiopathy (CAA) is characterized by amyloid-β aggregation in the media and adventitia of the leptomeningeal and cortical blood vessels. CAA is one of the strongest vascular contributors to Alzheimer’s disease (AD). It frequently co-occurs in AD patients, but the relationship between CAA and AD is incompletely understood. CAA may drive AD risk through damage to the neurovascular unit and accelerate parenchymal amyloid and tau deposition. Conversely, early AD may also drive CAA through cerebrovascular remodeling that impairs blood vessels from clearing amyloid-β. Sole reliance on autopsy examination to study CAA limits researchers’ ability to investigate CAA’s natural disease course and the effect of CAA on cognitive decline. Neuroimaging allows for in vivo assessment of brain function and structure and can be leveraged to investigate CAA staging and explore its associations with AD. In this review, we will discuss neuroimaging modalities that can be used to investigate markers associated with CAA that may impact AD vulnerability including hemorrhages and microbleeds, blood-brain barrier permeability disruption, reduced cerebral blood flow, amyloid and tau accumulation, white matter tract disruption, reduced cerebrovascular reactivity, and lowered brain glucose metabolism. We present possible areas for research inquiry to advance biomarker discovery and improve diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCerebral Amyloid AngiopathyHumansBrainAmyloid beta-PeptidesNeuroimagingAmyloidAmyloidogenic Proteins

Stichwörter der Autor:innen

Alzheimer’s diseaseamyloidcerebral amyloid angiopathymicrobleedsneuroimagingtauvascular dysfunction

Substanzen

Amyloid beta-PeptidesAmyloidAmyloidogenic Proteins

Autor:innen und Institutionen

  • Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina Del Rey, CA, USA.
  • Ethel Percy Andrus Gerontology Center, USC Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, USA.
  • Department of Biomedical Engineering, Corwin D. Denney Research Center, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA.

Förderung

  • NIA NIH HHS

Zitieren

APA

Wheeler, K. V., Irimia, A., & Braskie, M. N. (2024). Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer’s Disease. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-230553

Vancouver

Wheeler KV, Irimia A, Braskie MN. Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer’s Disease. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-230553

BibTeX
@article{Wheeler2024,
  author = {Wheeler, Koral V and Irimia, Andrei and Braskie, Meredith N},
  title = {Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer’s Disease},
  journal = {Journal of Alzheimer’s Disease},
  year = {2024},
  doi = {10.3233/jad-230553}
}
Kostenlos starten →